The Clatterbridge Cancer Centre NHS Foundation Trust announces start of construction on landmark facility
The Clatterbridge Cancer Centre NHS Foundation Trust and Laing O’Rourke have finalised the contract to build a new cancer hospital in Liverpool, with work starting on site.
Andrew Cannell, trust chief executive, said: “We are delighted to be working with Laing O’Rourke on this very-exciting development that will transform cancer care for this region.
“We have worked closely with staff and patient representatives on the design of the new building and we are all very excited to now see our plans taking shape in what will be a landmark for the area.
“The Clatterbridge Cancer Centre has a commitment to providing the very-best care for our patients. The new cancer hospital will allow us to do that.”
Bulk excavation and foundation works are now under way at the site, adjacent to the Royal Liverpool University Hospital and the University of Liverpool.
To mark the milestone, the site was recently visited by comedian, Johnny Vegas, whose father, Lol Pennington, was treated at the Wirral centre.
Laing O’Rourke’s head of UK building, Liam Cummins, said: “We look forward to using our engineering expertise and innovation in healthcare to deliver a new hospital for The Clatterbridge Cancer Centre NHS Foundation Trust.
“When the first patients are received into the new hospital in 2020 our team will be proud to have played some part in improving the facilities needed for specialist cancer care in Merseyside and Cheshire.”
Construction of the site is expected to be completed in the spring of 2020, with the new hospital expected to welcome its first patients in the summer of the same year.
It will provide specialist chemotherapy and other drug therapies, radiotherapy, inpatient and outpatient care, cancer support and rehabilitation, bone marrow transplant and urgent cancer care. There will also be a teenage and young adult unit.
It will care for people from across Merseyside and Cheshire and beyond who have solid tumours and blood cancers and will also carry out clinical trials of new cancer treatments.